Market News & Trends
OrphoMed Secures $39 Million
OrphoMed, Inc. recently announced the completion of a $39-million Series A financing. The round was led by New Enterprise Associates (NEA), and co-led by existing…
Teneobio & Poseida Announce License Agreement for the Use of UniDab in CAR T-Cell Therapy
Teneobio, Inc. and Poseida Therapeutics, Inc. recently announced they have entered a commercial license agreement for the use of Teneobio’s UniDabs, single-domain, human heavy chain…
Kamada Presents Updated Data From Phase 2 Clinical Trial for Inhaled Therapy
Kamada Ltd. recently announced that a poster comprising updated data from the company’s US Phase 2 clinical trial of its proprietary inhaled Alpha-1 Antitrypsin (AAT)…
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study
Inovio Pharmaceuticals, Inc. recently announced that its HIV vaccine, PENNVAX-GP, produced amongst the highest overall levels of immune response rates (cellular and humoral) ever demonstrated…
Hovione Announces Start of Phase 1 Clinical Trial
Hovione recently announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline…
Hovione Announces Start of Phase 1 Clinical Trial
Hovione recently announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline…
PCT Now a Global CDMO as Part of Hitachi Chemical
On May 18, 2017, PCT announced that Hitachi Chemical Co. America, Ltd. (Hitachi Chemical’s consolidated subsidiary) completed its purchase of the 80.1% remaining membership interest…
PCT Now a Global CDMO as Part of Hitachi Chemical
On May 18, 2017, PCT announced that Hitachi Chemical Co. America, Ltd. (Hitachi Chemical’s consolidated subsidiary) completed its purchase of the 80.1% remaining membership interest…
ABITEC’s Facility Expansion Promises New Manufacturing Capabilities
After producing quality products for more than 50 years, ABITEC is now reaping the rewards of a brand new expansion to their central Janesville facility.…
Aptar Pharma’s Electronic Nasal Lockout Device Receives Approved
Aptar Pharma, a world leader in innovative drug delivery systems, recently announced the approval by the European Medicines Agency (EMA) of the first integrated electronic…
Stable Economy Will Drive German Pharmaceuticals Market to $86.3 Billion
The German pharmaceuticals market is set to rise from $67.9 billion (€52.9 billion) in 2016 to around $86.3 billion (€67.2 billion) in 2021, representing a…
Catalent Biologics Announces Collaboration With Therachon
Catalent Pharma Solutions recently announced that it has signed an agreement with Therachon AG, a Swiss biotechnology company focused on rare genetic diseases, to support…
InveniAI is Launched With Industry-Leading Artificial Intelligence-Powered R&D Engine
BioXcel Corporation recently announced the formation of InveniAI to focus on maximizing the commercial potential of its proprietary pharma discovery and development engine, EvolverAI, and…
Cinfa Biotech Announces Positive Data for Biosimilar Candidate
Cinfa Biotech S.L., the biosimilars company of Cinfa Group, recently announced positive top-line data from the second clinical trial with its lead development candidate B12019,…
First-in-Class Innovation a Key Strategy for Pharmaceutical Companies in a Harsh Market Environment
Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when the risks of failure to…
First-in-Class Innovation a Key Strategy for Pharmaceutical Companies in a Harsh Market Environment
Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when the risks of failure to…
Thermo Fisher Scientific to Acquire Patheon for $7.2 Billion
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development…
Advances in Continuous Manufacturing of Drug Product, Commercial Spray Drying & HPAPIs/SDD at Hovione
Applying extensive knowledge, data, and a Development by Design (DbD) approach has enabled Hovione to accelerate spray drying development; reducing cost and time to get…
Sekisui XenoTech Awarded Cryopreservation Patent, Achieves Numerous Hepatocyte Enhancements
Sekisui XenoTech was recently issued US Patent No. 9,642,355 for the cryopreservation of cells and subcellular fractions,” specifically related to Sekisui XenoTech’s CryostaX test systems,…
Immunocore Identifies Second Novel ImmTAC in GSK Collaboration
Immunocore Limited recently announced it has identified a lead compound in its second discovery program with GSK. This novel ImmTAC lead molecule is relevant in…
